Enantigen Therapeutics — Department of Defense STTR Phase II: This project builds on patterns derived from natural antimicrobial peptide sequences to de
Enantigen Therapeutics — STTR Phase II award from Department of Defense.
- Amount
- $738,292
- Agency
- Department of Defense · Army
- Program / Phase
- STTR · Phase II
- Solicitation
- 2009.A
- NAICS
- —
- Place of performance
- PA
- Period
- 2011-12-16
Description
This project builds on patterns derived from natural antimicrobial peptide sequences to develop novel compounds with better systemic activity, lower cytotoxicity and broader spectrum activity against multidrug resistant (MDR) pathogens. In Phase I and the